Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) - Full Text View

Sponsor:	National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00051792

Purpose

The purpose of this study is to evaluate the safety and effectiveness of yoga in reducing shortness of breath in people with chronic obstructive pulmonary disease (COPD). Patients in this study must have moderate to severe COPD and be primarily limited by shortness of breath.

Condition	Intervention	Phase
Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Pulmonary Emphysema Chronic Bronchitis	Behavioral: yoga	Phase I Phase II

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Efficacy of Yoga for Self-Management of Dyspnea in COPD

Resource links provided by NLM:

MedlinePlus related topics: Breathing Problems COPD (Chronic Obstructive Pulmonary Disease) Chronic Bronchitis Emphysema

U.S. FDA Resources

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	36
Study Start Date:	January 2003
Estimated Study Completion Date:	July 2004

Detailed Description:

Management of dyspnea (shortness of breath) is a major concern for patients with COPD. The efficacy of complementary exercises to manage dyspnea is unknown. Complementary exercises may be more congruent with patients' lifestyles and values than traditional exercise programs and can be adapted to changes in illness severity and disability. Yoga practice is a complementary therapy that people use to manage their dyspnea. The aims of this study are to: 1) develop a safe and feasible yoga program for patients with COPD; 2) test the efficacy of this program; and 3) determine whether physical performance, psychological well being, and health-related quality of life are positively affected by yoga practice.

Patients in this study will be randomized to receive yoga training or usual care for 12 weeks. Patients will be evaluated at study entry, after each session, and immediately after the training program.

Eligibility

Ages Eligible for Study:	40 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Able to commit to a 12-week yoga class in San Francisco, California
Moderate to severe COPD, clinically stable for at least 1 month prior to study entry
Forced Expiratory Volume at one minute (FEV1) < 49% predicted after inhaled bronchodilator
Activities of daily living limited by shortness of breath
Ability to speak English and sign consent
Patients receiving supplemental oxygen will be acceptable if their O2 saturation can be maintained at > 85% on < 6 L/min of nasal oxygen

Exclusion criteria:

Symptomatic illness (e.g., cancer, left heart failure, ischemic heart disease, neuromuscular disease, psychiatric illness)
Formal pulmonary rehabilitation training within 1 year prior to study entry

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00051792

Locations

United States, California
University of California
San Francisco, California, United States

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators

Principal Investigator:

Virginia Carrieri-Kohlman, RN, DNSc

University of California, San Francisco

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00051792 History of Changes
Other Study ID Numbers:	R21 AT001168-01
Study First Received:	January 16, 2003
Last Updated:	August 16, 2006
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Bronchitis
Bronchitis, Chronic
Chronic Disease
Emphysema
Pulmonary Emphysema
Lung Diseases
Respiration Disorders

Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Bronchial Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on February 12, 2012